Showing results (81-90 of 315) with videos related to

Sort By:
Pageof 32
BJU International|October 6, 2018
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trialPaul F Pinsky, Eric Miller, Philip Prorok, et al.
The Journal of Urology|October 5, 2023
Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone AntagonistE David Crawford, Jason M Hafron, Frans Debruyne, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancerHind T Hatoum, E David Crawford, Sandy Kildegaard Nielsen, et al.
BJU International|February 26, 2009
Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-upLionel L Bañez, Gary W Blake, David G McLeod, et al.
The Journal of Urology|February 10, 2004
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysisRobert C Flanigan, G Mickisch, Richard Sylvester, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancerHind T Hatoum, E David Crawford, Sandy Kildegaard Nielsen, et al.
Urologic Oncology|January 14, 2011
Phase II evaluation of doxorubicin/vinblastine combined with inhibitors trifluoperazine/verapamil of P-glycoprotein in patients with advanced renal carcinomaL E Schroder, B A Blumenstein, R L Flanigan, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Therapeutic Advances in Medical Oncology|May 23, 2017
Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utilityE David Crawford, Neal D Shore, Daniel P Petrylak, et al.
Cancer Research|September 18, 2002
The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomyRobert A Gatenby, Edward T Gawlinski, Catherine M Tangen, et al.
Pageof 32